Contact us   |  

Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis

Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis

13/01/2022 17:00

Speakers: Arnauld Jaccard

Target: Health professionals
Subnetworks: Red blood cell defects
Disease Groups: AL Amyloidosis

To receive the access link to the Webinar, please register here:

* Fields are required